The Annual General Meeting of BioGaia AB (publ) was held on 7 May 2026 at 4.00 pm at Klara Konferens & Happynings, Klarabergsviadukten 90, Stockholm, at which the shareholders passed the resolutions s ...

The latest announcement is out from BioGaia AB ( ($SE:BIOG.B) ).

We're going to check out a few of the best picks from our screener tool. Overview: BioGaia AB (publ) is a healthcare company that offers probiotic products globally, with a market capitalization of ...

FIRST QUARTER 2026 Net sales amounted to SEK 372.6 million (366.3), an increase of SEK 6.3 million, an increase excluding currency effects of 15% (2% including currency effects). Net sales in the Pedi ...

Earnings call BioGaia delivered 13% organic revenue growth in Q2 2025 (5% reported), led by a 23% increase in adult health sales (ex-FX). EBIT declined 20% YoY due to a 25% rise in OpEx, mainly from U ...

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Results from a randomized, controlled pilot study in 76 infants with acute diarrhoea show that rapid diagnostic testing and Lactobacillus reuteri ...

BioGaia reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and strategic product launches. Sales for the quarter rose by 23% to SEK 365 million, while ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An ...

Infant Bacterial Therapeutics (IBT), a subsidiary of BioGaia, today announced that the IND (Investigational New Drug) for the prevention of necrotizing enterocolitis (NEC), has been accepted by the ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioGaia ...

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: A retrospective sequential analysis of 311 premature infants, born with a weight below 1000 grams, showed that prophylactic supplementation of ...